Αποτελέσματα Αναζήτησης
12 Ιουλ 2024 · Treating COVID-19. Medications to treat COVID-19 must be prescribed by a healthcare provider and started within 5–7 days after symptoms appear. Contact a healthcare provider right away to determine if you are eligible for treatment, even if your symptoms are mild.
27 Οκτ 2021 · Highly effective therapeutic agents directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19, are needed for these high-risk persons.
29 Φεβ 2024 · Recommendations for Treating Nonhospitalized Adults. The COVID-19 Treatment Guidelines Panel (the Panel) recommends the following anti-SARS-CoV-2 therapies as preferred treatments for COVID-19. These drugs are listed in order of preference: Ritonavir-boosted nirmatrelvir (Paxlovid) (AIIa) Remdesivir (BIIa)
15 Απρ 2024 · Prior to the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), drug discovery for coronavirus infections had been slow...
30 Ιουν 2024 · One study showed that Nafamostat (intravenous formulation) and camostat (oral formulation) have been discussed as TMPRSS2 inhibitors. They also analyzed whether it was associated with a reduced risk of 30-day all-cause mortality in adults with COVID-19.
In general, adults with SARS-CoV-2 infection can be grouped into the following severity of illness categories; however, the criteria for each category may overlap or vary across clinical guidelines and clinical trials, and a patient’s clinical status may change over time.
27 Νοε 2020 · Abstract. The disease caused by viral pneumonia called severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) declared by the World Health Organization is a global pandemic that the world has witnessed since the last Ebola epidemic, SARS and MERS viruses.
